{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:14:13Z","timestamp":1778922853829,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218676\/Z\/19\/Z\/WT"],"award-info":[{"award-number":["218676\/Z\/19\/Z\/WT"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["-002098"],"award-info":[{"award-number":["-002098"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["-005735"],"award-info":[{"award-number":["-005735"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/T008709\/1"],"award-info":[{"award-number":["BB\/T008709\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.lanmic.2024.100966","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T22:53:25Z","timestamp":1734389605000},"page":"100966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Artemether\u2013lumefantrine\u2013amodiaquine or artesunate\u2013amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ou\u00e9less\u00e9bougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Almahamoudou","family":"Mahamar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-385X","authenticated-orcid":false,"given":"Leen N","family":"Vanheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4629-2654","authenticated-orcid":false,"given":"Merel J","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koualy","family":"Sanogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssouf","family":"Sinaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidi M","family":"Niambele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makonon","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumar M","family":"Dicko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seydina O","family":"Maguiraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahamadou","family":"Youssouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adama","family":"Sacko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sekouba","family":"Keita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siaka","family":"Samake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adama","family":"Dembele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Teelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahia","family":"Dicko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sekou F","family":"Traore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjen","family":"Dondorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Drakeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alassane","family":"Dicko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2024.100966_bib1","series-title":"World malaria report 2023","year":"2023"},{"key":"10.1016\/j.lanmic.2024.100966_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum Malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N\u00a0Engl J\u00a0Med"},{"key":"10.1016\/j.lanmic.2024.100966_bib3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin\u2013piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2024.100966_bib4","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in\u00a0vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.lanmic.2024.100966_bib5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","article-title":"Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda","volume":"223","author":"Asua","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.lanmic.2024.100966_bib6","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1038\/s41467-023-39914-3","article-title":"Preventing antimalarial drug resistance with triple artemisinin-based combination therapies","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2024.100966_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2024.100966_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1473-3099(21)00692-7","article-title":"Triple therapy with artemether\u2013lumefantrine plus amodiaquine versus artemether\u2013lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial","volume":"22","author":"Peto","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2024.100966_bib9","series-title":"World malaria report 2021","year":"2021"},{"key":"10.1016\/j.lanmic.2024.100966_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12916-016-0621-7","article-title":"Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data","volume":"14","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.lanmic.2024.100966_bib11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(02)08348-4","article-title":"Amodiaquine\u2013artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial","volume":"359","author":"Adjuik","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2024.100966_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12936-022-04369-2","article-title":"Comparative effect of artemether\u2013lumefantrine and artesunate\u2013amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium\u00a0falciparum malaria in Madagascar","volume":"21","author":"Rakotoarisoa","year":"2022","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2024.100966_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035019","article-title":"Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence \u201ctransmission blocking\u201d assay","volume":"7","author":"Leli\u00e8vre","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2024.100966_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S2666-5247(24)00023-5","volume":"5","author":"Mahamar","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2024.100966_bib15","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/S2666-5247(21)00192-0","article-title":"Pyronaridine\u2013artesunate or dihydroartemisinin\u2013piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ou\u00e9less\u00e9bougou, Mali: a four-arm, single-blind, phase 2\u20133, randomised trial","volume":"3","author":"Stone","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2024.100966_bib16","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1016\/S2666-5247(21)00356-6","article-title":"Single low-dose tafenoquine combined with dihydroartemisinin\u2013piperaquine to reduce Plasmodium falciparum transmission in Ou\u00e9less\u00e9bougou, Mali: a phase 2, single-blind, randomised clinical trial","volume":"3","author":"Stone","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2024.100966_bib17","series-title":"Global malaria programme: WHO policy brief on single-dose primaquine as gametocytocide in Plasmodium falciparum malaria","year":"2014"},{"key":"10.1016\/j.lanmic.2024.100966_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S1473-3099(15)00479-X","article-title":"Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2\u00a0trial","volume":"16","author":"Dicko","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2024.100966_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1473-3099(18)30044-6","article-title":"Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial","volume":"18","author":"Dicko","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2024.100966_bib20","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S1473-3099(21)00072-4","article-title":"Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study","volume":"21","author":"Andolina","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2024.100966_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12936-018-2584-y","article-title":"A\u00a0multiplex assay for\u00a0the sensitive detection and quantification of male and female Plasmodium falciparum gametocytes","volume":"17","author":"Meerstein-Kessel","year":"2018","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2024.100966_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12936-017-1959-9","article-title":"Concentration of Plasmodium falciparum gametocytes in whole blood samples by magnetic cell sorting enhances parasite infection rates in mosquito feeding assays","volume":"16","author":"Reuling","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2024.100966_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1475-2875-9-136","article-title":"Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage\u00a0and the effect of gametocytocidal drugs","volume":"9","author":"Bousema","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2024.100966_bib24","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(19)31139-0","article-title":"Malaria eradication within a generation: ambitious, achievable, and necessary","volume":"394","author":"Feachem","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2024.100966_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/infdis\/jix237","article-title":"A\u00a0molecular assay to quantify male and female Plasmodium falciparum gametocytes: results from 2\u00a0randomized controlled trials using primaquine for gametocyte clearance","volume":"216","author":"Stone","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.lanmic.2024.100966_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0035-9203(00)90447-4","article-title":"The mosquito transmission of malaria: the effects of atovaquone\u2013proguanil (Malarone) and chloroquine","volume":"94","author":"Enosse","year":"2000","journal-title":"Trans R\u00a0Soc Trop Med Hyg"},{"key":"10.1016\/j.lanmic.2024.100966_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104805","article-title":"Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria","volume":"96","author":"Mukaka","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lanmic.2024.100966_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00898-20","article-title":"Transmission of artemisinin-resistant malaria parasites to mosquitoes under antimalarial drug pressure","volume":"65","author":"Witmer","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2024.100966_bib29","series-title":"WHO Malaria Policy Advisory Group (MPAG) meeting report","year":"2023"},{"key":"10.1016\/j.lanmic.2024.100966_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12879-015-0887-y","article-title":"Mass campaigns with antimalarial drugs: a modelling comparison of artemether\u2013lumefantrine and DHA\u2013piperaquine with and without primaquine as tools for malaria control and elimination","volume":"15","author":"Gerardin","year":"2015","journal-title":"BMC Infect Dis"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524724002192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524724002192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:41:59Z","timestamp":1778920919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524724002192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2666524724002192"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2024.100966","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artemether\u2013lumefantrine\u2013amodiaquine or artesunate\u2013amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ou\u00e9less\u00e9bougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2024.100966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100966"}}